Global Stem Cells Market to Reach $19.1 Billion by 2030
The global market for Stem Cells estimated at US$10.7 Billion in the year 2022, is projected to reach a revised size of US$19.1 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2022-2030. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$16 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 6.8% CAGR
The Stem Cells market in the U.S. is estimated at US$3.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.Select Competitors (Total 233 Featured) -
- apceth Biopharma GmbH
- Athersys Inc.
- AVIVA BioSciences Corporation
- BioE Inc.
- Bone Therapeutics SA
- Cesca Therapeutics Inc.
- Cryo-Cell International Inc.
- Cytori Therapeutics Inc.
- ESI BIO
- Gamida Cell Ltd.
- Holostem Terapie Avanzate
- International Stem Cell Corp.
- Kangstem Biotech. Ltd.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Neuralstem Inc.
- Nuvasive Inc.
- OncoMed Pharmaceuticals Inc.
- Osiris Therapeutics Inc.
- Promethera Biosciences S.A.N.V
- Reliance Life Sciences
- ReNeuron Group Plc.
- Stemcell Technologies Inc.
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd.
- Takara Bio USA Inc.
- TiGenix NV
- U.S Stem Cell Inc.
- ViaCord
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- apceth Biopharma GmbH
- Athersys Inc.
- AVIVA BioSciences Corporation
- BioE Inc.
- Bone Therapeutics SA
- Cesca Therapeutics Inc.
- Cryo-Cell International Inc.
- Cytori Therapeutics Inc.
- ESI BIO
- Gamida Cell Ltd.
- Holostem Terapie Avanzate
- International Stem Cell Corp.
- Kangstem Biotech. Ltd.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Neuralstem Inc.
- Nuvasive Inc.
- OncoMed Pharmaceuticals Inc.
- Osiris Therapeutics Inc.
- Promethera Biosciences S.A.N.V
- Reliance Life Sciences
- ReNeuron Group Plc.
- Stemcell Technologies Inc.
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd.
- Takara Bio USA Inc.
- TiGenix NV
- U.S Stem Cell Inc.
- ViaCord
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 369 |
Published | May 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 9.1 Billion |
Forecasted Market Value ( USD | $ 15.1 Billion |
Compound Annual Growth Rate | 7.5% |
Regions Covered | Global |